This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A health care provider is participating in a clinical trial of a new drug. Which statement should ... (Read 134 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
on: Jul 23, 2018
A health care provider is participating in a clinical trial of a new drug. Which statement should the health care provider communicate to the participant in this type of pharmacoeconomic analy-sis?
 
  a. The clinical trial is designed to provide incentives for competitors to lower the costs of a specific drug.
  b. The clinical trial is designed to allow open participation by anyone wishing to try the new drug.
  c. The clinical trial is designed to determine how to provide the drug at the lowest possible cost.
  d. The clinical trial is designed to evaluate the safety and efficacy of a specific drug.

Question 2

A cost-of-illness analysis is conducted for diabetes mellitus. Which of the following variables would be expected to be included in such a study?
 
  a. Comparison of costs with the assumption that the outcomes of all interventions are equal
  b. Client preferences regarding treatment options and life-years saved
  c. Direct costs of medical services and indirect costs from loss of productivity due to illness
  d. The outcome of treatment in terms of a natural health unit (reduction in serum glucose level)


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nhea

  • Sr. Member
  • ****
  • Posts: 305
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: D
The majority of pharmacoeconomic analyses are piggy-backed onto clinical trials evaluating the efficacy and safety of a specific treatment or intervention. The Food and Drug Administration (FDA) requests that pharmacoeconomic analyses be attached to clinical trials. Economic data are collected as part of the clinical trial and used to determine the cost-effectiveness of the treatment under study.

Answer to Question 2

ANS: C
A cost-of-illness analysis measures both direct and indirect costs associated with an illness. The other choices refer to cost-minimization, cost-utility, and cost-effectiveness analyses, respective-ly.


Capo

  • Member
  • Posts: 545
Reply 2 on: Jul 23, 2018
Excellent

amit

  • Member
  • Posts: 364
Reply 3 on: Yesterday
Great answer, keep it coming :)

« previous next »
 

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Patients with physical special needs, such as a wheelchair, need to have this documented in their he Patients with physical special needs, such as a wheelchair, need to have this documented in their he
The Increasing Cost of Health Care, 1960–2010 The Increasing Cost of Health Care, 1960–2010
Types of Health Insurance Service Coverage Types of Health Insurance Service Coverage
Drug Classification and Description of Use Drug Classification and Description of Use
Drug Classification and Description of Use Drug Classification and Description of Use
Single-dose drug administration. Pharmacokinetic values for this drug are as follows: onset of ... Single-dose drug administration. Pharmacokinetic values for this drug are as follows: onset of ...
Video: Steps of glucose catabolism

For a complete list of videos, visit our video library